{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:02:23Z","timestamp":1790640143287,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jocn.2026.112067","type":"journal-article","created":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T03:39:45Z","timestamp":1778297985000},"page":"112067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Factors associated with initial exacerbation after corticosteroids treatment in myasthenia gravis patients with bulbar symptoms"],"prefix":"10.1016","volume":"151","author":[{"given":"Xinxin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiucheng","family":"xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2026.112067_b0005","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jocn.2026.112067_b0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: Executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2026.112067_b0015","doi-asserted-by":"crossref","DOI":"10.1177\/17562864231213240","article-title":"Guideline for the management of myasthenic syndromes","volume":"16","author":"Wiendl","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.jocn.2026.112067_b0020","first-page":"7","article-title":"The Japanese Clinical guidelines 2022 for Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome: an Overview","volume":"76","author":"Murai","year":"2024","journal-title":"Brain Nerve"},{"key":"10.1016\/j.jocn.2026.112067_b0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12974-022-02448-4","article-title":"Independent risk factors for myasthenic crisis and disease exacerbation in a retrospective cohort of myasthenia gravis patients","volume":"19","author":"Nelke","year":"2022","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.jocn.2026.112067_b0030","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archneur.1985.04060110031011","article-title":"High-dose intravenous methylprednisolone in myasthenia gravis","volume":"42","author":"Arsura","year":"1985","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jocn.2026.112067_b0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jns.2018.10.018","article-title":"Predictive score for oral corticosteroid-induced initial worsening of seropositive generalized myasthenia gravis","volume":"396","author":"Kanai","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2026.112067_b0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-0404.1998.tb05968.x","article-title":"Treatment of myasthenia gravis with methylprednisolone pulse: a double blind study","volume":"97","author":"Lindberg","year":"1998","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jocn.2026.112067_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116740","article-title":"Initial deterioration and intravenous methylprednisolone therapy in patients with myasthenia gravis","volume":"412","author":"Sugimoto","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2026.112067_b0050","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jocn.2005.12.041","article-title":"Clinical predictors of steroid-induced exacerbation in myasthenia gravis","volume":"13","author":"Bae","year":"2006","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2026.112067_b0055","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1212\/WNL.26.8.729","article-title":"Long-term administration of corticosteroids in myasthenia gravis","volume":"26","author":"Mann","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2026.112067_b0060","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/WNL.22.6.603","article-title":"Corticosteroids in management of severe, generalized myasthenia gravis: Effectiveness and comparison with corticotropin therapy","volume":"22","author":"Brunner","year":"1972","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2026.112067_b0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2026.112067_b0070","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","article-title":"Myasthenia gravis activities of daily living profile","volume":"52","author":"Wolfe","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2026.112067_b0075","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1212\/01.WNL.0000163988.28892.79","article-title":"Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity","volume":"64","author":"Bedlack","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2026.112067_b0080","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1749-6632.1998.tb11015.x","article-title":"Reliability testing of the quantitative myasthenia gravis score","volume":"841","author":"Barohn","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jocn.2026.112067_b0085","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1007\/s00415-020-10264-0","article-title":"Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review","volume":"268","author":"Lotan","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.jocn.2026.112067_b0090","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1749-6632.1976.tb47719.x","article-title":"Long-term prednisone followed by thymectomy in myasthenia gravis","volume":"274","author":"Mann","year":"1976","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jocn.2026.112067_b0095","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ana.410150316","article-title":"Long-term corticosteroid treatment of myasthenia gravis: report of 116 patients","volume":"15","author":"Pascuzzi","year":"1984","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2026.112067_b0100","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000322497","article-title":"Early aggressive treatment strategy against myasthenia gravis","volume":"65","author":"Nagane","year":"2011","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jocn.2026.112067_b0105","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/jnnp.68.2.214","article-title":"Extraocular muscle responses to high dose intravenous methylprednisolone in myasthenia gravis","volume":"68","author":"Komiyama","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2026.112067_b0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2019.05.003","article-title":"Efficacy of high-dose intravenous methylprednisolone therapy for ocular myasthenia gravis","volume":"402","author":"Ozawa","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2026.112067_b0115","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.48.5.1253","article-title":"Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation","volume":"48","author":"Thomas","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2026.112067_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116530","article-title":"Preoperative risks of post-operative myasthenic crisis (POMC): a meta-analysis","volume":"407","author":"Akaishi","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2026.112067_b0125","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/ana.25087","article-title":"A clinical predictive score for postoperative myasthenic crisis","volume":"82","author":"Kanai","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2026.112067_b0130","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s10072-022-06493-y","article-title":"Nomogram for the acute exacerbation of acetylcholine receptor antibody-positive generalized myasthenia gravis","volume":"44","author":"Chen","year":"2023","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jocn.2026.112067_b0135","first-page":"2884","article-title":"Correlation factors of 127 times pre-crisis state in patients with myasthenia gravis","volume":"97","author":"Changyi","year":"2017","journal-title":"National Medical J China"},{"key":"10.1016\/j.jocn.2026.112067_b0140","first-page":"2438","article-title":"Factors related to myasthenic crisis in myasthenia gravis patients with oropharyngeal involvement during hospitalization","volume":"101","author":"Liu","year":"2021","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"24","key":"10.1016\/j.jocn.2026.112067_b0145","first-page":"00396","article-title":"Laryngeal Dysfunction Manifesting as Chronic Refractory Cough and Dyspnea: Laryngeal Physiology in respiratory Health and Disease","volume":"S0012\u20133692","author":"Sundar","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.jocn.2026.112067_b0150","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1378\/chest.14-1481","article-title":"Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel report","volume":"146","author":"Canning","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.jocn.2026.112067_b0155","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.2147\/IJGM.S426321","article-title":"Pulmonary Function Assessment in Myasthenia Gravis patients in a National Referral Hospital in Indonesia","volume":"16","author":"Octaviana","year":"2023","journal-title":"IJGM"},{"key":"10.1016\/j.jocn.2026.112067_b0160","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/1759-7714.14799","article-title":"Surgical safety analysis and clinical experience sharing of myasthenia gravis patients aged 65 and over","volume":"14","author":"Jiao","year":"2023","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.jocn.2026.112067_b0165","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1183\/09031936.93.01020119","article-title":"Changes in respiratory muscle function after neostigmine injection in patients with myasthenia gravis","volume":"1","author":"Radwan","year":"1988","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jocn.2026.112067_b0170","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/mus.10378","article-title":"Maximal voluntary ventilation in myasthenia gravis","volume":"27","author":"Heliopoulos","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2026.112067_b0175","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jocn.2026.112067_b0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3390\/brainsci14020157","article-title":"Calculated Maximal volume Ventilation (cMVV) as a Marker of Early respiratory failure in Amyotrophic Lateral Sclerosis (ALS)","volume":"14","author":"Manera","year":"2024","journal-title":"Brain Sci"},{"key":"10.1016\/j.jocn.2026.112067_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120143","article-title":"Respiratory function tests in amyotrophic lateral sclerosis: the role of maximal voluntary ventilation","volume":"434","author":"de Carvalho","year":"2022","journal-title":"J Neurol Sci"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826002183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826002183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:36:44Z","timestamp":1790638604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586826002183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S0967586826002183"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112067","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors associated with initial exacerbation after corticosteroids treatment in myasthenia gravis patients with bulbar symptoms","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112067"}}